Introduction
============

Calcium pyrophosphate dihydrate crystal deposition (CPPD) or pseudogout is the third most common type of inflammatory arthritis. As compared to osteoarthritis, CPPD is associated with higher levels of inflammation, pain, stiffness, and functional limitation \[[@b1-asj-2018-0280]\]. Induced inflammation is associated with pain, stiffness, and functional limitation in the affected joints. CPPD of the spine is a rare disease. CPPD in the lumbar area of the spinal structure (SCPPD) can be found in the intervertebral disc ([Fig. 1](#f1-asj-2018-0280){ref-type="fig"}) \[[@b2-asj-2018-0280]\], disk fibrocartilage \[[@b3-asj-2018-0280]\], ligamentum flavum \[[@b4-asj-2018-0280],[@b5-asj-2018-0280]\], and facet joint \[[@b6-asj-2018-0280]-[@b8-asj-2018-0280]\]. The prevalence varies as per the spinal structure that is affected. Berlemann et al. \[[@b2-asj-2018-0280]\] reported incidental CPPD in 12.6% of lumbar intervertebral discs. Yayama et al. \[[@b4-asj-2018-0280]\] identified CPPD in 36.66% of ligamentum flavum samples, and Markiewitz et al. \[[@b5-asj-2018-0280]\] reported CPPD in the ligamentum flavum in 24.5% of surgically treated patients. Inflammation in these structures may cause pain in the affected area as well as neuropathic pain that may be attributable to inflamed neural structures or compressive effect of the inflamed tissues. Common clinical presentations include back pain and/or radiating leg pain \[[@b6-asj-2018-0280],[@b8-asj-2018-0280]\] that may mimic infection, cauda equina syndrome \[[@b9-asj-2018-0280]\], spinal epidural hematoma \[[@b10-asj-2018-0280]\], and spinal stenosis \[[@b11-asj-2018-0280]-[@b14-asj-2018-0280]\]. However, the clinical significance of SCPPD in patients who present with lumbar spinal stenosis (LSS) remains unclear. We hypothesized that posterior spinal surgery to correct LSS should increase inflammation in SCPPD patients as compared to that in non-SCPPD patients and that total removal of these structures may be necessary. We further hypothesized that different levels of inflammation and pathology in the two conditions would result in dissimilar pain levels and clinical outcomes. However, as per our literature review, no studies have validated these hypotheses. Thus, we aimed to study the effects of SCPPD in LSS patients.

This study aimed to investigate the association of surgical intervention with the clinical and quality of life (QoL) outcomes in patients who underwent posterior spinal surgery for LSS with SCPPD versus that in those who underwent the surgery for LSS without SCPPD.

Materials and Methods
=====================

This study was conducted at a university-based tertiary referral center. The protocol for this study was approved by the Siriraj Institutional Review Board, Faculty of Medicine Siriraj Hospital, Mahidol University (IRB approval no., Si233/2014).

A single-institution database was reviewed, identifying LSS patients who were surgically treated with posterior spinal surgery during the 2003--2011 study period. All the LSS patients were categorized as those with and without SCPPD. Definite diagnosis of SCPPD was confirmed using histologic identification of calcium pyrophosphate (CPP). Clinical presentations, complications, and postoperative results of both the groups were analyzed.

SCPPD patients who underwent decompressive laminectomy and/or fusion were included after histopathologic diagnosis. Non-SCPPD patients were then matched using demographic data. Patients were excluded if their medical chart contained incomplete data and/or the follow-up period was \<2 years.

All the patients underwent decompressive laminectomy with or without discectomy as per the clinical and magnetic resonance imaging findings ([Fig. 2](#f2-asj-2018-0280){ref-type="fig"}). No patient underwent total removal of CPP-involved tissues or steroid injection (adequate decompression was confirmed in all cases without total facetectomy or total discectomy). Spinal fusion with or without instrumentation was performed if the patient had significant back pain or instability. Ligamentum flavum, facet capsule, and disc specimens were sent for histopathologic examination for all patients. The enrolled patients were divided into the following two groups: SCPPD group (18/34) and non-SCPPD group (16/34) as per the histopathologic report. Patients in the SCPPD group did not receive colchicine postoperatively.

Data were collected via chart abstraction; demographic data, clinical presentations, operative data, radiographic findings, and postoperative data were recorded. Pain was evaluated using the Verbal Rating Scale (VRS) (range, 0--10). All the patients completed the 36-item Short-Form Health Survey (SF-36) version 2.0 questionnaire (Thai version) \[[@b15-asj-2018-0280]\] and the Oswestry Disability Index (ODI) low back pain version 1.0 questionnaire (Thai version) \[[@b16-asj-2018-0280]\] before the surgery and at the last follow-up. Informed consent was obtained from all patients at the last followup. Fusion was evaluated using plain radiographs.

Descriptive statistics, including mean, standard deviation, median, minimum, maximum, and range values, were calculated for quantitative data, while frequencies were calculated for categorical and ordinal variables. Mann-Whitney *U*-test and chi-square test were used to compare continuous variables and categorical variables, respectively. A *p*-value \<0.05 was considered statistically significant. Data were analyzed using the SPSS statistics ver. 13.0 (SPSS Inc., Chicago, IL, USA).

Results
=======

Thirty-four patients (15 men and 19 women) were enrolled, with 18 patients allocated to the SCPPD group and 16 to the non-SCPPD group. Demographic, clinical, and operative data are shown in [Table 1](#t1-asj-2018-0280){ref-type="table"}. The mean operative time and mean intraoperative blood loss were not significantly different between the groups. The mean follow-up duration was 61.9 months (range, 41--92 months).

The demographic data of the groups were comparable; however, the mean body mass index (BMI) of the SCPPD group was significantly lower than that of the non-SCPPD group (23.56 kg/m^2^ versus 26.47 kg/m^2^, *p*=0.015). The commonly affected levels in both the groups were L4--5, L3--4, and L5--S1. No patient had a history of CPPD in other joints. Fourteen of the 18 SCPPD patients and 11 of the 16 non-SCPPD patients underwent spinal fusion. None of these patients required additional surgery because of nonunion or surgical complications.

Preoperative and postoperative pain scores were not significantly different between the groups (*p*=0.33 and *p*=0.48, respectively). The average preoperative ODI score in the SCPPD group was slightly higher than that in the non-SCPPD group (57 versus 51, *p*=0.33); however, the postoperative score was significantly lower (15 versus 43, *p*=0.01). Physical function, vitality, and mental health were also significantly improved in the SCPPD group at the last follow-up (*p*=0.03, *p*=0.022, and *p*=0.022, respectively). Regarding other items and summary scores, no statistically significant differences were observed between the groups. Preoperative and postoperative VRS, ODI, and SF-36 data are shown in [Table 2](#t2-asj-2018-0280){ref-type="table"}. There were no statistically significant differences in the postoperative scores among the three operative procedures. Subgroup analysis of the SCPPD group for each operative procedure is presented in [Table 3](#t3-asj-2018-0280){ref-type="table"}; no significant differences were detected among the three surgical procedures.

Discussion
==========

The present study revealed that SCPPD group patients had a significantly higher average age than the non-SCPPD group patients. SCPPD group patients also had higher levels of back pain than the non-SCPPD group patients; however, the difference in the pain levels of the groups was not statistically significant. Preoperative pain score, percentage of back pain, ODI, and SF-36 score were not significantly different between the groups, although the SCPPD group patients had a significantly lower BMI. This finding may indicate that inflammation in CPP-involved tissue plays the role. The most common affected levels were L4--5 and L3--4 in both the groups. Markiewitz et al. \[[@b5-asj-2018-0280]\] reported that SCPPD patients had more acute symptoms with similar clinical presentation. No pathognomonic sign of SCPPD has been reported in the literature. Although facet cyst is reportedly associated with SCPPD, we found that the incidence of facet cyst was comparable in the two groups.

Very few studies have described the surgical treatment in SCPPD patients. Mahmud et al. \[[@b17-asj-2018-0280]\] reported successful relief of symptoms in SCPPD patients after surgical decompression and/or fusion. However, to our knowledge, no study has reported any comparison between SCPPD and non-SCPPD in LSS. The authors hypothesized that surgical intervention would result in more inflammation in patients with LSS and SCPPD who already had more inflammatory features than LSS patients without SCPPD. The present study revealed comparable pain and overall QoL in the groups after the surgical treatment, although total removal of CPP-involved tissues was not performed for any patient. There was no statistically significant difference between the groups in terms of preoperative disability, pain, and QoL. Although the SCPPD group patients showed significantly better postoperative clinical results for disability, physical function, vitality, and mental health, there was no significant difference between the groups for overall physical and mental health at the last follow-up. Operative procedures (i.e., fusion and instrumentation) may not correlate with postoperative function because the subgroup analysis did not detect any significant differences among the three surgical procedures. This may be attributable to selection bias. The authors conclude that total removal of CPP-involved tissues is not mandatory, given that all SCPPD group patients demonstrated significant improvement in pain, ODI, and SF-36 QoL scores. Limitations of this study included the fact that it was a single-center retrospective study and involved a relatively small number of participants. In this study, we determined fusion using plain radiographs. Computed tomography scan would have been more accurate for evaluating fusion. A large, prospective multi-center study may be able to obtain additional information on the clinical impact of SCPPD in degenerative spine disease.

Conclusions
===========

To our knowledge, this is the first study to investigate the effect of CPPD on clinical and QoL outcomes in surgically treated LSS patients. Surgical intervention resulted in good clinical outcomes in SCPPD patients. As per our findings, total removal of CPP-involved tissue is not necessary for outcome improvement. Thus, surgery should be performed as indicated based on the clinical presentation without considering the presence of CPPD.
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![(A) Intervertebral disc (H&E staining, ×400) shows minimal calcium pyrophosphate dihydrate deposition (purple staining material in the center). (B) The purple staining material shows rhomboid-shaped crystals on polarized light.](asj-2018-0280f1){#f1-asj-2018-0280}

![(A--D) demonstrated preoperative plain radiograph and T2-weighted MRI of 67-year-old woman who had severe back pain with bilateral radicular pain, underwent laminectomy and uninstrumented posterolateral fusion. (D) Axial T2-weighted magnetic resonance image showed cystic mass originated from ligamentum flavum without calcification at L3--4 level. (E--H) Postoperative plain radiographs and MRI of the same patient. MRI, magnetic resonance imaging.](asj-2018-0280f2){#f2-asj-2018-0280}

###### 

Demographic, clinical, and operative data

  Characteristic                            SCPPD group (N=18)   Non-SCPPD group (N=16)   *p*-value
  ----------------------------------------- -------------------- ------------------------ -----------
  Gender (female)                           12 (66.7)            7 (43.8)                 0.179
  Age (yr)                                  71±5.6               65.9±9.7                 0.064
  Body mass index (kg/m^2^)                 23.6±3.4             26.5±3.0                 0.015
  ASA class 1/2/3                           2/14/2               3/12/1                   0.751
  Underlying disease                                                                      0.457
   Hypertension                             14 (77.8)            12 (75.0)                
   Diabetes mellitus                        4 (22.2)             6 (37.5)                 
   Dyslipidemia                             10 (55.6)            7 (43.8)                 
   Gout                                     1 (5.6)              1 (6.3)                  
  Smoker                                    0                    0                        NS
  Chief complaint                                                                         0.011
   Back pain                                8 (44.4)             1 (6.3)                  
   Radicular pain                           3 (16.7)             2 (12.5)                 
   Neurodeficit                             2 (11.1)             0                        
   Claudication                             5 (27.8)             13 (81.3)                
  Radiographic finding                                                                    0.642
   Spondylolisthesis                        11 (61.1)            11 (68.8)                
   Magnetic resonance imaging: facet cyst   2 (11.1)             2 (12.5)                 
  Affected level                                                                          0.236
   L1--2                                    0                    1                        
   L2--3                                    2                    0                        
   L3--4                                    10                   7                        
   L4--5                                    15                   12                       
   L5--S1                                   8                    4                        
  No. of involved spine                                                                   0.63
   1                                        11                   11                       
   2                                        14                   15                       
   3                                        8                    5                        
   4                                        0                    1                        
  Cases presented with revision surgery     2 (11.1)             0                        0.487
  Types of surgery                                                                        0.593
   DCL                                      4                    5                        
   DCL+PLF                                  11                   10                       
   DCL+instrumented PLF                     3                    1                        
  Operative time (min)                      151.7±28.9           143.1±25.2               0.367
  Intraoperative blood loss (mL)            553±426              519±276                  0.798
  Complications                                                                           0.487
   Nerve injury                             0                    0                        
   Dural tear                               2                    0                        

Values are presented as number (%), mean±standard deviation, or number. *p*-value \<0.05 indicates statistical significance.

SCPPD, spinal calcium pyrophosphate dihydrate deposition; ASA, American Society of Anesthesiologists; NS, not significant; DCL, decompressive laminectomy; PLF, posterolateral fusion.

###### 

Preoperative and postoperative VRS, ODI, and SF-36 data

  Variable                        SCPPD group (N=18)   Non-SCPPD group (N=16)   *p*-value
  ------------------------------- -------------------- ------------------------ -----------
  VRS                                                                           
   Preoperative score             8.0                  7.0                      0.330
   Postoperative score            3.0                  3.0                      0.480
   Improvement                    6.5                  4.0                      0.130
  ODI                                                                           
   Preoperative score             57.0                 51.0                     0.330
   Postoperative score            15.0                 43.0                     0.010
   Improvement                    34.0                 15.0                     0.010
  Physical functioning                                                          
   Preoperative score             25.0                 22.5                     0.443
   Postoperative score            50.0                 25.0                     0.003
   Improvement                    -12.5                -5.0                     0.237
  Role-physical                                                                 
   Preoperative score             0                    0                        0.510
   Postoperative score            12.5                 0                        0.551
   Improvement                    0                    0                        0.986
  Bodily pain                                                                   
   Preoperative score             41.0                 41.0                     0.959
   Postoperative score            72.0                 53.0                     0.551
   Improvement                    -15.5                -11.5                    0.798
  General health                                                                
   Preoperative score             45.0                 41.0                     0.670
   Postoperative score            61.0                 52.0                     0.095
   Improvement                    -16.0                -8.5                     0.330
  Vitality                                                                      
   Preoperative score             52.5                 40.0                     0.075
   Postoperative score            62.5                 50.0                     0.022
   Improvement                    -2.5                 -2.5                     0.646
  Social functioning                                                            
   Preoperative score             75.0                 62.5                     0.224
   Postoperative score            75.0                 62.5                     0.198
   Improvement                    -6.25                0                        0.878
  Role-elemental                                                                
   Preoperative score             0                    0                        0.551
   Postoperative score            66.7                 0                        0.154
   Improvement                    0                    0                        0.506
  Mental health                                                                 
   Preoperative score             66.0                 52.0                     0.313
   Postoperative score            78.0                 62.0                     0.022
   Improvement                    -10.0                0                        0.443
  Physical health summary scale                                                 
   Preoperative score             25.9                 28.8                     0.746
   Postoperative score            36.4                 35.3                     0.251
   Improvement                    -7.3                 -3.6                     0.463
  Mental health summary scale                                                   
   Preoperative score             45.0                 39.7                     0.175
   Postoperative score            51.2                 43.7                     0.081
   Improvement                    -6.0                 0.5                      0.313

Values are presented as median. *p*-value \<0.05 indicates statistical significance.

VRS, Verbal Rating Scale; ODI, Oswestry Disability Index; SF-36, 36-item Short-Form Health Survey; SCPPD, spinal calcium pyrophosphate dihydrate deposition.

###### 

Subgroup analysis for each operative procedure in spinal calcium pyrophosphate dihydrate deposition group patients

  Variable                        DCL (n=4)   DCL+PLF (n=11)   DCL+instrumented PLF (n=3)   *p*-value
  ------------------------------- ----------- ---------------- ---------------------------- -----------
  VRS                                                                                       
   Preoperative score             9           8                5                            0.054
   Postoperative score            1           3                1                            0.348
   Improvement                    7           6                4                            
  ODI                                                                                       
   Preoperative score             74          56               22                           0.181
   Postoperative score            5           16               8                            0.147
   Improvement                    57          32               14                           
  Physical functioning                                                                      
   Preoperative score             35          20               45                           0.185
   Postoperative score            45          50               45                           0.950
   Improvement                    -10         -30              0                            
  Role-physical                                                                             
   Preoperative score             37.5        0                50                           0.030
   Postoperative score            37.5        0                75                           0.086
   Improvement                    -12.5       0                -25                          
  Bodily pain                                                                               
   Preoperative score             62          22               74                           0.014
   Postoperative score            74          62               74                           0.175
   Improvement                    -21.5       -29              0                            
  General health                                                                            
   Preoperative score             45          45               75                           0.074
   Postoperative score            57          57               77                           0.244
   Improvement                    -24.5       -15              -2                           
  Vitality                                                                                  
   Preoperative score             60          50               60                           0.322
   Postoperative score            70          55               70                           0.058
   Improvement                    -7.5        5                10                           
  Social functioning                                                                        
   Preoperative score             87.5        62.5             75                           0.032
   Postoperative score            87.5        62.5             75                           0.136
   Improvement                    6.25        -12.5            12.5                         
  Role-elemental                                                                            
   Preoperative score             33.4        0                33.3                         0.349
   Postoperative score            66.7        66.7             33.3                         0.960
   Improvement                    -33.4       0                0                            
  Mental health                                                                             
   Preoperative score             82          52               76                           0.171
   Postoperative score            78          80               76                           0.877
   Improvement                    -2          -24              0                            
  Physical health summary scale                                                             
   Preoperative score             35.6        23.6             48                           0.039
   Postoperative score            36.8        34.2             45.3                         0.096
   Improvement                    -6.2        -11.6            0.7                          
  Mental health summary scale                                                               
   Preoperative score             49.8        44.7             51.1                         0.319
   Postoperative score            53          50.2             42.8                         0.632
   Improvement                    -7          -5.5             -2                           

Values are presented as median. *p*-value\<0.05 indicates statistical significance.

DCL, decompressive laminectomy; PLF, posterolateral fusion; VRS, Verbal Rating Scale; ODI, Oswestry Disability Index.
